HEADER OXIDOREDUCTASE 28-JAN-21 7E0G TITLE CRYSTAL STRUCTURE OF LYSINE SPECIFIC DEMETHYLASE 1 (LSD1) WITH TAK- TITLE 2 418, FAD-ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BRAF35-HDAC COMPLEX PROTEIN BHC110,FLAVIN-CONTAINING AMINE COMPND 5 OXIDASE DOMAIN-CONTAINING PROTEIN 2,[HISTONE H3]-DIMETHYL-L-LYSINE(4) COMPND 6 FAD-DEPENDENT DEMETHYLASE 1A; COMPND 7 EC: 1.14.99.66; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KDM1A, AOF2, KDM1, KIAA0601, LSD1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, TAK-418, FAD-ADDUCT, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR H.OKI REVDAT 2 29-NOV-23 7E0G 1 REMARK REVDAT 1 24-MAR-21 7E0G 0 JRNL AUTH R.BABA,S.MATSUDA,Y.ARAKAWA,R.YAMADA,N.SUZUKI,T.ANDO,H.OKI, JRNL AUTH 2 S.IGAKI,M.DAINI,Y.HATTORI,S.MATSUMOTO,M.ITO,A.NAKATANI, JRNL AUTH 3 H.KIMURA JRNL TITL LSD1 ENZYME INHIBITOR TAK-418 UNLOCKS ABERRANT EPIGENETIC JRNL TITL 2 MACHINERY AND IMPROVES AUTISM SYMPTOMS IN NEURODEVELOPMENTAL JRNL TITL 3 DISORDER MODELS. JRNL REF SCI ADV V. 7 2021 JRNL REFN ESSN 2375-2548 JRNL PMID 33712455 JRNL DOI 10.1126/SCIADV.ABA1187 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REFMAC_5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 49246 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2576 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5022 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 73 REMARK 3 SOLVENT ATOMS : 208 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.91000 REMARK 3 B22 (A**2) : 0.91000 REMARK 3 B33 (A**2) : -2.96000 REMARK 3 B12 (A**2) : 0.46000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.193 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.179 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.149 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.292 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7E0G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1300020541. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51851 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 159.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.29 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 11.60 REMARK 200 R MERGE FOR SHELL (I) : 0.99800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2Z5U REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M IMIDAZOLE/HCL (PH 7.0), 14% PEG REMARK 280 3350, 10% 2-METHYL-2,4-PENTANEDIOL, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.19033 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 72.38067 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 54.28550 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 90.47583 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 18.09517 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 36.19033 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 72.38067 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 90.47583 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 54.28550 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 18.09517 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1284 LIES ON A SPECIAL POSITION. REMARK 375 HOH A1308 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 169 REMARK 465 GLY A 170 REMARK 465 SER A 171 REMARK 465 GLN A 460 REMARK 465 GLN A 461 REMARK 465 TYR A 462 REMARK 465 LYS A 463 REMARK 465 GLU A 464 REMARK 465 ALA A 465 REMARK 465 SER A 466 REMARK 465 GLU A 467 REMARK 465 VAL A 468 REMARK 465 LYS A 469 REMARK 465 PRO A 470 REMARK 465 PRO A 471 REMARK 465 ARG A 472 REMARK 465 ASP A 473 REMARK 465 PRO A 784 REMARK 465 SER A 785 REMARK 465 ILE A 786 REMARK 465 PRO A 787 REMARK 465 GLY A 788 REMARK 465 ALA A 789 REMARK 465 PRO A 790 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 634 C - N - CD ANGL. DEV. = -13.6 DEGREES REMARK 500 PRO A 641 C - N - CD ANGL. DEV. = -21.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 240 39.25 -94.26 REMARK 500 ASP A 245 48.23 -83.12 REMARK 500 SER A 286 50.41 -117.95 REMARK 500 MET A 332 -10.53 -142.96 REMARK 500 ASN A 514 55.93 -115.98 REMARK 500 PRO A 634 101.32 34.35 REMARK 500 PRO A 641 108.71 37.20 REMARK 500 PRO A 701 47.52 -84.83 REMARK 500 ALA A 757 -55.01 -127.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 240 PRO A 241 132.30 REMARK 500 GLN A 633 PRO A 634 -118.81 REMARK 500 VAL A 640 PRO A 641 -108.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1307 DISTANCE = 5.91 ANGSTROMS REMARK 525 HOH A1308 DISTANCE = 7.61 ANGSTROMS DBREF 7E0G A 172 833 UNP O60341 KDM1A_HUMAN 172 833 SEQADV 7E0G GLY A 169 UNP O60341 EXPRESSION TAG SEQADV 7E0G GLY A 170 UNP O60341 EXPRESSION TAG SEQADV 7E0G SER A 171 UNP O60341 EXPRESSION TAG SEQRES 1 A 665 GLY GLY SER SER GLY VAL GLU GLY ALA ALA PHE GLN SER SEQRES 2 A 665 ARG LEU PRO HIS ASP ARG MET THR SER GLN GLU ALA ALA SEQRES 3 A 665 CYS PHE PRO ASP ILE ILE SER GLY PRO GLN GLN THR GLN SEQRES 4 A 665 LYS VAL PHE LEU PHE ILE ARG ASN ARG THR LEU GLN LEU SEQRES 5 A 665 TRP LEU ASP ASN PRO LYS ILE GLN LEU THR PHE GLU ALA SEQRES 6 A 665 THR LEU GLN GLN LEU GLU ALA PRO TYR ASN SER ASP THR SEQRES 7 A 665 VAL LEU VAL HIS ARG VAL HIS SER TYR LEU GLU ARG HIS SEQRES 8 A 665 GLY LEU ILE ASN PHE GLY ILE TYR LYS ARG ILE LYS PRO SEQRES 9 A 665 LEU PRO THR LYS LYS THR GLY LYS VAL ILE ILE ILE GLY SEQRES 10 A 665 SER GLY VAL SER GLY LEU ALA ALA ALA ARG GLN LEU GLN SEQRES 11 A 665 SER PHE GLY MET ASP VAL THR LEU LEU GLU ALA ARG ASP SEQRES 12 A 665 ARG VAL GLY GLY ARG VAL ALA THR PHE ARG LYS GLY ASN SEQRES 13 A 665 TYR VAL ALA ASP LEU GLY ALA MET VAL VAL THR GLY LEU SEQRES 14 A 665 GLY GLY ASN PRO MET ALA VAL VAL SER LYS GLN VAL ASN SEQRES 15 A 665 MET GLU LEU ALA LYS ILE LYS GLN LYS CYS PRO LEU TYR SEQRES 16 A 665 GLU ALA ASN GLY GLN ALA VAL PRO LYS GLU LYS ASP GLU SEQRES 17 A 665 MET VAL GLU GLN GLU PHE ASN ARG LEU LEU GLU ALA THR SEQRES 18 A 665 SER TYR LEU SER HIS GLN LEU ASP PHE ASN VAL LEU ASN SEQRES 19 A 665 ASN LYS PRO VAL SER LEU GLY GLN ALA LEU GLU VAL VAL SEQRES 20 A 665 ILE GLN LEU GLN GLU LYS HIS VAL LYS ASP GLU GLN ILE SEQRES 21 A 665 GLU HIS TRP LYS LYS ILE VAL LYS THR GLN GLU GLU LEU SEQRES 22 A 665 LYS GLU LEU LEU ASN LYS MET VAL ASN LEU LYS GLU LYS SEQRES 23 A 665 ILE LYS GLU LEU HIS GLN GLN TYR LYS GLU ALA SER GLU SEQRES 24 A 665 VAL LYS PRO PRO ARG ASP ILE THR ALA GLU PHE LEU VAL SEQRES 25 A 665 LYS SER LYS HIS ARG ASP LEU THR ALA LEU CYS LYS GLU SEQRES 26 A 665 TYR ASP GLU LEU ALA GLU THR GLN GLY LYS LEU GLU GLU SEQRES 27 A 665 LYS LEU GLN GLU LEU GLU ALA ASN PRO PRO SER ASP VAL SEQRES 28 A 665 TYR LEU SER SER ARG ASP ARG GLN ILE LEU ASP TRP HIS SEQRES 29 A 665 PHE ALA ASN LEU GLU PHE ALA ASN ALA THR PRO LEU SER SEQRES 30 A 665 THR LEU SER LEU LYS HIS TRP ASP GLN ASP ASP ASP PHE SEQRES 31 A 665 GLU PHE THR GLY SER HIS LEU THR VAL ARG ASN GLY TYR SEQRES 32 A 665 SER CYS VAL PRO VAL ALA LEU ALA GLU GLY LEU ASP ILE SEQRES 33 A 665 LYS LEU ASN THR ALA VAL ARG GLN VAL ARG TYR THR ALA SEQRES 34 A 665 SER GLY CYS GLU VAL ILE ALA VAL ASN THR ARG SER THR SEQRES 35 A 665 SER GLN THR PHE ILE TYR LYS CYS ASP ALA VAL LEU CYS SEQRES 36 A 665 THR LEU PRO LEU GLY VAL LEU LYS GLN GLN PRO PRO ALA SEQRES 37 A 665 VAL GLN PHE VAL PRO PRO LEU PRO GLU TRP LYS THR SER SEQRES 38 A 665 ALA VAL GLN ARG MET GLY PHE GLY ASN LEU ASN LYS VAL SEQRES 39 A 665 VAL LEU CYS PHE ASP ARG VAL PHE TRP ASP PRO SER VAL SEQRES 40 A 665 ASN LEU PHE GLY HIS VAL GLY SER THR THR ALA SER ARG SEQRES 41 A 665 GLY GLU LEU PHE LEU PHE TRP ASN LEU TYR LYS ALA PRO SEQRES 42 A 665 ILE LEU LEU ALA LEU VAL ALA GLY GLU ALA ALA GLY ILE SEQRES 43 A 665 MET GLU ASN ILE SER ASP ASP VAL ILE VAL GLY ARG CYS SEQRES 44 A 665 LEU ALA ILE LEU LYS GLY ILE PHE GLY SER SER ALA VAL SEQRES 45 A 665 PRO GLN PRO LYS GLU THR VAL VAL SER ARG TRP ARG ALA SEQRES 46 A 665 ASP PRO TRP ALA ARG GLY SER TYR SER TYR VAL ALA ALA SEQRES 47 A 665 GLY SER SER GLY ASN ASP TYR ASP LEU MET ALA GLN PRO SEQRES 48 A 665 ILE THR PRO GLY PRO SER ILE PRO GLY ALA PRO GLN PRO SEQRES 49 A 665 ILE PRO ARG LEU PHE PHE ALA GLY GLU HIS THR ILE ARG SEQRES 50 A 665 ASN TYR PRO ALA THR VAL HIS GLY ALA LEU LEU SER GLY SEQRES 51 A 665 LEU ARG GLU ALA GLY ARG ILE ALA ASP GLN PHE LEU GLY SEQRES 52 A 665 ALA MET HET HUF A1001 55 HET GOL A1002 6 HET IMD A1003 5 HET IMD A1004 5 HET MG A1005 1 HET MG A1006 1 HETNAM HUF [[(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4- HETNAM 2 HUF BIS(OXIDANYL)OXOLAN-2-YL]METHOXY-OXIDANYL-PHOSPHORYL] HETNAM 3 HUF [(2R,3S,4S)-5-[5-METHANOYL-7,8-DIMETHYL-2,4- HETNAM 4 HUF BIS(OXIDANYLIDENE)-1H-BENZO[G]PTERIDIN-10-YL]-2,3,4- HETNAM 5 HUF TRIS(OXIDANYL)PENTYL] HYDROGEN PHOSPHATE HETNAM GOL GLYCEROL HETNAM IMD IMIDAZOLE HETNAM MG MAGNESIUM ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 HUF C28 H35 N9 O16 P2 FORMUL 3 GOL C3 H8 O3 FORMUL 4 IMD 2(C3 H5 N2 1+) FORMUL 6 MG 2(MG 2+) FORMUL 8 HOH *208(H2 O) HELIX 1 AA1 SER A 172 SER A 181 1 10 HELIX 2 AA2 THR A 189 PHE A 196 1 8 HELIX 3 AA3 PHE A 196 SER A 201 1 6 HELIX 4 AA4 PRO A 203 ASN A 224 1 22 HELIX 5 AA5 THR A 230 LEU A 238 1 9 HELIX 6 AA6 PRO A 241 SER A 244 5 4 HELIX 7 AA7 ASP A 245 HIS A 259 1 15 HELIX 8 AA8 GLY A 287 PHE A 300 1 14 HELIX 9 AA9 ASN A 340 ASN A 350 1 11 HELIX 10 AB1 PRO A 371 GLN A 395 1 25 HELIX 11 AB2 SER A 407 GLU A 457 1 51 HELIX 12 AB3 THR A 475 ASN A 514 1 40 HELIX 13 AB4 SER A 522 ALA A 541 1 20 HELIX 14 AB5 PRO A 543 LEU A 547 5 5 HELIX 15 AB6 ASP A 555 GLU A 559 5 5 HELIX 16 AB7 SER A 572 GLU A 580 1 9 HELIX 17 AB8 PRO A 626 GLN A 632 1 7 HELIX 18 AB9 PRO A 644 MET A 654 1 11 HELIX 19 AC1 GLY A 709 GLU A 716 1 8 HELIX 20 AC2 SER A 719 GLY A 736 1 18 HELIX 21 AC3 SER A 769 GLN A 778 1 10 HELIX 22 AC4 GLY A 800 ILE A 804 5 5 HELIX 23 AC5 THR A 810 GLY A 831 1 22 SHEET 1 AA1 5 ASP A 583 LYS A 585 0 SHEET 2 AA1 5 ASP A 303 LEU A 307 1 N LEU A 306 O LYS A 585 SHEET 3 AA1 5 LYS A 280 ILE A 284 1 N VAL A 281 O ASP A 303 SHEET 4 AA1 5 ALA A 620 CYS A 623 1 O LEU A 622 N ILE A 282 SHEET 5 AA1 5 LEU A 796 PHE A 798 1 O PHE A 797 N CYS A 623 SHEET 1 AA2 2 THR A 319 LYS A 322 0 SHEET 2 AA2 2 TYR A 325 ASP A 328 -1 O ALA A 327 N PHE A 320 SHEET 1 AA3 3 VAL A 333 VAL A 334 0 SHEET 2 AA3 3 LEU A 565 VAL A 567 -1 O LEU A 565 N VAL A 334 SHEET 3 AA3 3 LEU A 353 LYS A 355 -1 N ALA A 354 O THR A 566 SHEET 1 AA4 6 LEU A 362 TYR A 363 0 SHEET 2 AA4 6 LEU A 677 HIS A 680 1 O GLY A 679 N TYR A 363 SHEET 3 AA4 6 LEU A 693 TRP A 695 -1 O PHE A 694 N PHE A 678 SHEET 4 AA4 6 ILE A 702 VAL A 707 -1 O LEU A 704 N TRP A 695 SHEET 5 AA4 6 ASN A 660 CYS A 665 -1 N LEU A 664 O LEU A 703 SHEET 6 AA4 6 GLU A 745 VAL A 748 -1 O VAL A 747 N VAL A 663 SHEET 1 AA5 2 VAL A 400 LEU A 401 0 SHEET 2 AA5 2 LYS A 404 PRO A 405 -1 O LYS A 404 N LEU A 401 SHEET 1 AA6 4 THR A 613 CYS A 618 0 SHEET 2 AA6 4 GLY A 599 ASN A 606 -1 N CYS A 600 O CYS A 618 SHEET 3 AA6 4 THR A 588 THR A 596 -1 N ARG A 594 O GLU A 601 SHEET 4 AA6 4 GLN A 638 VAL A 640 1 O GLN A 638 N ARG A 591 SHEET 1 AA7 2 GLY A 655 PHE A 656 0 SHEET 2 AA7 2 SER A 762 TYR A 763 -1 O TYR A 763 N GLY A 655 LINK MG MG A1005 O HOH A1290 1555 5554 2.97 CRYST1 184.550 184.550 108.571 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005419 0.003128 0.000000 0.00000 SCALE2 0.000000 0.006257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009211 0.00000